Caspofungin

Echinocandin (lipopeptide)Rx: PrescriptionCompound: Approved

Also known as: Cancidas, CAS 179861-57-2, Caspofungin acetate, L-743,872, MK-0991

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Caspofungin at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Caspofungin is a semisynthetic cyclic lipopeptide antifungal (echinocandin) administered intravenously for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis.

Mechanism of Action

Inhibits fungal β-(1,3)-D-glucan synthase, impairing cell wall synthesis

Routes of Administration

Intravenous

Goals & Uses

  • Treatment of invasive aspergillosisAntifungalHigh
  • Antifungal prophylaxis in high-risk patientsProphylaxisModerate
  • Treatment of invasive candidiasisAntifungalHigh
  • Treatment of esophageal candidiasisAntifungal TherapyHigh
  • Prophylaxis in neutropenic patientsPreventionModerate
  • Empirical antifungal therapy in febrile neutropeniaAntifungal Prophylaxis/empirical TherapyHigh

Contraindications

  • Concomitant use with cyclosporine (relative)Drug InteractionModerate
  • Severe hepatic impairment (Child‑Pugh C)Liver DiseaseModerate
  • Hypersensitivity to caspofungin or any echinocandinAllergyHigh
  • Known hypersensitivity to caspofungin or any componentAllergyHigh

Adverse Effects

  • Elevated liver enzymes (AST/ALT)HepatotoxicityCommon
  • HypokalemiaElectrolyteCommon
  • AnaphylaxisImmunologicRareSevere life-threatening allergic reaction
  • Nausea/vomitingGastrointestinalUncommon
  • Infusion‑related reactions (fever, chills, rigors)SystemicCommon
  • Rash or pruritusDermatologicUncommon
  • Infusion-related reactions (flushing, rash, pruritus)Infusion ReactionUncommon
  • FeverSystemicCommonElevated body temperature
  • Elevated liver transaminases (ALT/AST)HepaticCommon
  • DiarrheaGastrointestinalUncommonLoose or frequent stools

Drug Interactions

  • RifampinModerate
  • CyclosporineModerate
  • Efavirenz/Nevirapine/Carbamazepine/Phenytoin/DexamethasoneModerate
  • TacrolimusModerate

Population Constraints

  • Pregnancy (Category C)ReproductiveRelative
  • PregnancyReproductive SafetyRelative
  • Pediatric patients (<18 years)AgeRelative
  • Pediatric patients under 3 monthsAgeRelative
  • Severe hepatic impairment (Child-Pugh >9)HepaticRelative
  • BreastfeedingReproductiveRelative

Regulatory Status

  • European UnionApprovedApproved: Invasive candidiasis, Esophageal candidiasis, Invasive aspergillosisSame as US
  • United StatesApprovedApproved: Invasive candidiasis, Esophageal candidiasis, Invasive aspergillosisIV formulation only
  • United KingdomApprovedApproved: Invasive candidiasis, Esophageal candidiasis, Invasive aspergillosisMarketed as Cancidas

FDA approved in 2001 (Cancidas); also approved in the EU and UK. Available only as an intravenous formulation.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is Caspofungin?

Caspofungin is a semisynthetic cyclic lipopeptide antifungal (echinocandin) administered intravenously for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis.

What is Caspofungin used for?

Caspofungin is educationally associated with: Treatment of invasive aspergillosis, Antifungal prophylaxis in high-risk patients, Treatment of invasive candidiasis, Treatment of esophageal candidiasis, Prophylaxis in neutropenic patients, Empirical antifungal therapy in febrile neutropenia. Educational only — not medical advice.

How is Caspofungin administered?

Recorded routes of administration: Intravenous.

What are the potential side effects of Caspofungin?

Reported adverse effects include: Elevated liver enzymes (AST/ALT), Hypokalemia, Anaphylaxis, Nausea/vomiting, Infusion‑related reactions (fever, chills, rigors), Rash or pruritus, Infusion-related reactions (flushing, rash, pruritus), Fever, Elevated liver transaminases (ALT/AST), Diarrhea. This list is not exhaustive — consult a qualified clinician.

Who should avoid Caspofungin?

Recorded contraindications: Concomitant use with cyclosporine (relative), Severe hepatic impairment (Child‑Pugh C), Hypersensitivity to caspofungin or any echinocandin, Known hypersensitivity to caspofungin or any component. Consult a qualified clinician before use.